相似文献
1
Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations.
Blood Adv. 2017 Apr 25;1(11):699-702. doi: 10.1182/bloodadvances.2017005082.
2
Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
Blood Adv. 2017 Apr 25;1(11):703-706. doi: 10.1182/bloodadvances.2017005090.
3
Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.
Blood Adv. 2017 Feb 14;1(6):401-406. doi: 10.1182/bloodadvances.2016002188.
4
ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint.
Blood Adv. 2017 Mar 28;1(9):573-576. doi: 10.1182/bloodadvances.2016001552.
5
Related haploidentical donors are a better choice than matched unrelated donors: Point.
Blood Adv. 2017 Feb 14;1(6):397-400. doi: 10.1182/bloodadvances.2016002196.
6
Should minimal residual disease negativity be the end point of myeloma therapy?
Blood Adv. 2017 Mar 14;1(8):517-521. doi: 10.1182/bloodadvances.2016000117.
7
Platelets and hemostasis: a new perspective on an old subject.
Blood Adv. 2016 Nov 22;1(1):5-9. doi: 10.1182/bloodadvances.2016000059. eCollection 2016 Nov 29.
8
ATG in allogeneic stem cell transplantation: standard of care in 2017? Point.
Blood Adv. 2017 Mar 28;1(9):569-572. doi: 10.1182/bloodadvances.2016001560.
9
Should minimal residual disease negativity be the end point of myeloma therapy?
Blood Adv. 2017 Mar 14;1(8):522-525. doi: 10.1182/bloodadvances.2017000109.
10
Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies.
Blood Adv. 2016 Dec 27;1(3):260-264. doi: 10.1182/bloodadvances.2016000042.
引用本文的文献
1
Von Willebrand Disease: Current Status of Diagnosis and Management.
Hematol Oncol Clin North Am. 2021 Dec;35(6):1085-1101. doi: 10.1016/j.hoc.2021.07.004. Epub 2021 Aug 13.
本文引用的文献
1
Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention?: A systematic review and meta-analysis.
Medicine (Baltimore). 2017 Jan;96(1):e5653. doi: 10.1097/MD.0000000000005653.
2
Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
N Engl J Med. 2017 Jan 12;376(2):136-148. doi: 10.1056/NEJMoa1606424. Epub 2016 Oct 23.
3
Obstetric bleeding among women with inherited bleeding disorders: a retrospective study.
Haemophilia. 2016 Nov;22(6):906-911. doi: 10.1111/hae.13067. Epub 2016 Oct 5.
4
Bleeding related to disturbed fibrinolysis.
Br J Haematol. 2016 Oct;175(1):12-23. doi: 10.1111/bjh.14255. Epub 2016 Aug 1.
5
The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial.
Trials. 2016 May 17;17(1):249. doi: 10.1186/s13063-016-1332-2.
6
Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial.
Br J Anaesth. 2016 May;116(5):641-8. doi: 10.1093/bja/aew021.
7
Tranexamic Acid for Prevention PPH: a Promising Drug But Today Only a Promising Drug.
Transfus Med Rev. 2016 Apr;30(2):100. doi: 10.1016/j.tmrv.2016.01.003. Epub 2016 Feb 8.
8
Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series.
Am J Kidney Dis. 2016 Jul;68(1):50-7. doi: 10.1053/j.ajkd.2015.11.022. Epub 2016 Jan 16.
9
Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database.
Haemophilia. 2015 Sep;21(5):e442-5. doi: 10.1111/hae.12739. Epub 2015 Jul 20.
10
Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery.
J Matern Fetal Neonatal Med. 2016;29(10):1617-22. doi: 10.3109/14767058.2015.1056731. Epub 2015 Jun 29.
Zotero 插件